Sponsored by Julius Baer
Blackhorn Wealth & Health VIP Dinner 2026
In an increasingly complex global environment, lasting success is defined not only by the preservation of wealth, but also by the ability to sustain health, vitality, and purpose over the long term.
Blackhorn Wealth & Health VIP Dinner 2026 brings together perspectives from private banking and leading healthcare professionals to explore the vital connection between strategic wealth planning and proactive health management.
Designed as an intimate gathering for distinguished guests, the evening offers thoughtful dialogue, expert insights, and meaningful exchange on how informed decisions today can shape financial resilience, longevity, and legacy
Date: Thursday, 4 June 2026
Time: 6:00 pm – 10:00 pm
Venue: The Lounge, M Floor, Grand Hyatt
RSVP:
Please contact your Client Advisor
Expert Perspectives
Mr. Alan Lee
Head of Investment Strategy, Blackhorn
Alan Lee leads Blackhorn’s investment strategy, overseeing market analysis and portfolio positioning to help clients navigate evolving global markets. With a disciplined and forward‑looking approach, Alan focuses on translating macroeconomic insights into strategic investment decisions aligned with long‑term wealth objectives.
Mr. Richard Tang
Head of Research, Hong Kong, Julius Baer
Richard Tang heads Julius Baer’s research function in Hong Kong, providing market intelligence and investment perspectives across global asset classes. His work supports informed decision‑making amid economic uncertainty, with a particular focus on long‑term trends shaping global wealth.
Dr Kenneth Tsang
Regional Chief Executive Officer, IHH Healthcare North Asia
Chief Executive Officer, Gleneagles Hospital Hong Kong
Dr Kenneth Tsang spearheads IHH Healthcare North Asia, an integrated healthcare network encompassing multi-specialty hospitals, primary and specialist clinics, ambulatory care centres, and laboratory and pharmacy services in Hong Kong and Shanghai via the respective brands Gleneagles Hong Kong and Parkway Shanghai. In conjunction with his regional role, Dr Tsang oversees Gleneagles Hospital Hong Kong as Chief Executive Officer. He also provides leadership for Gleneagles Clinical Trials Centre, contributing to healthcare innovation and advancement in Hong Kong and nearby regions.
Supported by
